Literature DB >> 28521489

Identification of proteins with different abundance associated with cell migration and proliferation in leiomyoma interstitial fluid by proteomics.

Blendi Ura1, Federica Scrimin1, Cinzia Franchin2,3, Giorgio Arrigoni2,3, Danilo Licastro4, Lorenzo Monasta1, Giuseppe Ricci1,5.   

Abstract

Uterine leiomyoma is the most common female reproductive tract benign tumor. Little is known about protein composition and changes in the leiomyoma interstitial fluid (IF). The present study focused on changes in protein abundance in the IF of leiomyoma. Leiomyoma IFs and adjacent myometrial IFs were obtained and analyzed by two-dimensional electrophoresis (2-DE) coupled with mass spectrometry and western blotting for 2-DE data validation. A total of 25 unique proteins were observed to change significantly (P<0.05). Of these proteins with different abundance, 22 had not been previously identified in leiomyoma IF. In silico analysis predicted that three of these proteins were secreted via classical mechanisms, while 22 were secreted via non-classical mechanisms. Ingenuity Pathway Analysis identified 17 proteins associated with cellular migration and proliferation. Among these, phosphoglycerate mutase 1 had not been previously associated with leiomyoma. The abundance of seven proteins was further validated by western blotting. A comparative proteomic approach identified a number of proteins associated with cellular migration and proliferation, with changes in abundance in IF likely to be involved in tumor development. Further studies will be required to investigate the role of these proteins in leiomyoma IF and their possible association with tumor development and growth.

Entities:  

Keywords:  2-D electrophoresis; interstitial fluid; leiomyoma; mass spectrometry; myometrium; proteomics; secreted protein

Year:  2017        PMID: 28521489      PMCID: PMC5431234          DOI: 10.3892/ol.2017.5943

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  37 in total

1.  Novel method to characterize primary cultures of leiomyoma and myometrium with the use of confirmatory biomarker gene arrays.

Authors:  Minnie Malik; William H Catherino
Journal:  Fertil Steril       Date:  2007-01-12       Impact factor: 7.329

2.  Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma.

Authors:  John M Norian; Carter M Owen; Juan Taboas; Casey Korecki; Rocky Tuan; Minnie Malik; William H Catherino; James H Segars
Journal:  Matrix Biol       Date:  2011-09-24       Impact factor: 11.583

3.  Abnormal expression of leiomyoma cytoskeletal proteins involved in cell migration.

Authors:  Blendi Ura; Federica Scrimin; Giorgio Arrigoni; Emmanouil Athanasakis; Michelangelo Aloisio; Lorenzo Monasta; Giuseppe Ricci
Journal:  Oncol Rep       Date:  2016-03-17       Impact factor: 3.906

Review 4.  α-Enolase: a promising therapeutic and diagnostic tumor target.

Authors:  Michela Capello; Sammy Ferri-Borgogno; Paola Cappello; Francesco Novelli
Journal:  FEBS J       Date:  2011-02-24       Impact factor: 5.542

5.  Two-dimensional gel electrophoresis analysis of the leiomyoma interstitial fluid reveals altered protein expression with a possible involvement in pathogenesis.

Authors:  Blendi Ura; Federica Scrimin; Fabrizio Zanconati; Giorgio Arrigoni; Lorenzo Monasta; Andrea Romano; Rubina Banco; Marina Zweyer; Daniela Milani; Giuseppe Ricci
Journal:  Oncol Rep       Date:  2015-03-03       Impact factor: 3.906

6.  Adenylyl cyclase-associated protein-1/CAP1 as a biological target substrate of gelatinase B/MMP-9.

Authors:  Bénédicte Cauwe; Erik Martens; Philippe E Van den Steen; Paul Proost; Ilse Van Aelst; Daniel Blockmans; Ghislain Opdenakker
Journal:  Exp Cell Res       Date:  2008-07-16       Impact factor: 3.905

7.  Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene.

Authors:  K Hashimoto; C Azuma; S Kamiura; T Kimura; T Nobunaga; T Kanai; M Sawada; S Noguchi; F Saji
Journal:  Gynecol Obstet Invest       Date:  1995       Impact factor: 2.031

8.  Retinoic acid pathway genes show significantly altered expression in uterine fibroids when compared with normal myometrium.

Authors:  Marina Zaitseva; Beverley J Vollenhoven; Peter A W Rogers
Journal:  Mol Hum Reprod       Date:  2007-06-06       Impact factor: 4.025

9.  Changes in protein expression in two cholangiocarcinoma cell lines undergoing formation of multicellular tumor spheroids in vitro.

Authors:  Carlo Mischiati; Blendi Ura; Leda Roncoroni; Luca Elli; Carlo Cervellati; Monica Squerzanti; Dario Conte; Luisa Doneda; Patrizia Polverino de Laureto; Giorgia de Franceschi; Roberta Calza; Carlos A Barrero; Salim Merali; Carlo Ferrari; Carlo M Bergamini; Enzo Agostinelli
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

10.  A Proteomic Approach for the Identification of Up-Regulated Proteins Involved in the Metabolic Process of the Leiomyoma.

Authors:  Blendi Ura; Federica Scrimin; Giorgio Arrigoni; Cinzia Franchin; Lorenzo Monasta; Giuseppe Ricci
Journal:  Int J Mol Sci       Date:  2016-04-09       Impact factor: 5.923

View more
  3 in total

1.  Dysregulated chaperones associated with cell proliferation and negative apoptosis regulation in the uterine leiomyoma.

Authors:  Blendi Ura; Federica Scrimin; Giorgio Arrigoni; Michelangelo Aloisio; Lorenzo Monasta; Giuseppe Ricci
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

2.  Proteomic Study Identifies Glycolytic and Inflammation Pathways Involved in Recurrent Otitis Media.

Authors:  Blendi Ura; Fulvio Celsi; Luisa Zupin; Giorgio Arrigoni; Ilaria Battisti; Bartolomea Gaita; Domenico Leonardo Grasso; Eva Orzan; Raffaella Sagredini; Egidio Barbi; Sergio Crovella
Journal:  Int J Mol Sci       Date:  2020-12-05       Impact factor: 5.923

3.  Gel-Based Proteomic Identification of Suprabasin as a Potential New Candidate Biomarker in Endometrial Cancer.

Authors:  Fulvio Celsi; Lorenzo Monasta; Giorgio Arrigoni; Ilaria Battisti; Danilo Licastro; Michelangelo Aloisio; Giovanni Di Lorenzo; Federico Romano; Giuseppe Ricci; Blendi Ura
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.